Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials

Published:2020-03 Issue: Volume:20 Page:100271
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Nielsen Ole Haagen,Steenholdt Casper,Juhl Carsten Bogh,Rogler Gerhard

Publisher

Elsevier BV

Subject

General Medicine

Reference79 articles.

1. Biosimilars for management of Crohn disease;Nielsen;Ann Intern Med,2019

2. Novel targeted therapies for inflammatory bowel disease;Coskun;Trends Pharmacol Sci,2017

3. Targeting JAK-STAT signal transduction in IBD;Soendergaard;Pharmacol Ther,2018

4. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management;Gomollon;J Crohns Colitis,2017

5. ACG clinical guideline: management of Crohn’s disease in adults;Lichtenstein;Am J Gastroenterol,2018

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems;Pharmaceutics;2024-09-07

2. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

3. Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-01

4. Diagnosis and management of inflammatory bowel disease;Journal of Evidence-Based Medicine;2024-06

5. Postoperative Ustekinumab Drug Levels and Disease Activity in Patients with Crohn’s Disease;Digestive Diseases and Sciences;2024-05-24